Plants and microorganisms constitute a major source of natural products with desirable
bioactive properties. Fungi are among the most important groups of eukaryotic organisms
that are being explored for metabolites for clinical applications. Existing drugs of fungal
origin include β-lactam anti-biotics, griseofulvin, cyclosporine A, taxol, ergot alkaloids, and
lovastatin; however increasingly more new natural products of varied chemical structures are
reported to be produced by fungi.